ArchPoint Investors’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-92,500
| Closed | -$886K | – | 60 |
|
|
2022
Q3 | $886K | Sell |
92,500
-1,500
| -2% | -$14.4K | 0.36% | 37 |
|
|
2022
Q2 | $1.04M | Sell |
94,000
-500
| -0.5% | -$5.52K | 0.41% | 33 |
|
|
2022
Q1 | $1.57M | Hold |
94,500
| – | – | 0.54% | 32 |
|
|
2021
Q4 | $1.8M | Hold |
94,500
| – | – | 0.54% | 33 |
|
|
2021
Q3 | $2.33M | Sell |
94,500
-2,944
| -3% | -$72.6K | 0.7% | 25 |
|
|
2021
Q2 | $2.54M | Buy |
97,444
+25,276
| +35% | +$658K | 0.86% | 24 |
|
|
2021
Q1 | $2.29M | Buy |
72,168
+3,000
| +4% | +$95K | 0.65% | 26 |
|
|
2020
Q4 | $3.21M | Buy |
69,168
+57,418
| +489% | +$2.66M | 0.89% | 27 |
|
|
2020
Q3 | $387K | Buy |
+11,750
| New | +$387K | 0.12% | 71 |
|
|
2019
Q1 | – | Sell |
-5,000
| Closed | -$44K | – | 136 |
|
|
2018
Q4 | $44K | Buy |
+5,000
| New | +$44K | 0.02% | 96 |
|